Sunday 11 January 2009
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2009
(368)
-
▼
January
(43)
- SAFC Pharma has commenced operations at its 700m2 ...
- Excelsyn reports strong sales; strengthens capabil...
- Socma sees weaker outlook for 2009
- Goodwin Biotechnology has completed the first phas...
- Johnson Matthey saw Q3 sales of research chemicals...
- DSM Pharmaceutical Products has joined the Americ...
- Albemarle sees record fine chemicals income
- Pfizer to close five manufacturing plants
- Lonza reports strong year
- Rohm and Haas sues Dow to force takeover
- Cytovance Biologics will develop a process for and...
- Pfizer confirms Wyeth bid
- Saltigo expands US site
- Wyeth has withdrawn from its negotiations to acqui...
- Dow wins FTC approval for Rohm and Haas takeover
- Pfizer to buy Wyeth
- Lonza starts-up Nansha API plant
- Science not politics for FDA
- More than 100 pharmaceutical patents - including t...
- Cambrex will use its high-grade benzoyl peroxide i...
- RAG still plans an IPO for Evonik
- Cobra Biomanufacturing will manufacture Scancell’s...
- Vivalis will develop a process and manufacture a m...
- Richter-Helm BioLogics will develop and manufactur...
- Lonza in biosimilars deal with Teva
- Angel Biotechnology saw its share price rise as Re...
- Ranbaxy considers purchase of US manufacturing fac...
- Prosonix will use its ultrasonic particle engineer...
- Cel-Sci to support drug development programme thro...
- BayBio calls for California’s leaders to promote b...
- Lonza invests $26m in 4100m2 Walkersville expansion
- FDA launches safety pilot programme
- Agencies launch inspection sharing programme
- Jubilant Organosys and BioLeap have started a drug...
- SOCMA reveals "First 100 days" priorities
- Sanofi-Aventis refuses to confirm links to Crucell
- FDA opens Costa Rica office
- FDA Committee recommends GTC's goat-produced drug
- Wyeth in negotiations to acquire Crucell
- Teva will use Codexis technology to produce a gene...
- Dow Chemical is expected to reduce its offer for R...
- FDA approvals in 2008 highest for three years
- Rhodia closes last paracetamol plant in Europe
-
▼
January
(43)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment